Our journals offer ESMO members and the oncology community a globally visible platform to publish scientific studies, and a highly credible source of educational updates.
There are many good reasons to become an ESMO member. Find out why you should join Europe's leading medical oncology society
An annual Congress providing a comprehensive overview of all the practice-changing new data. Register now!
The ESMO-MCBS scale is a validated and reproducible tool to assess the magnitude of clinical benefit for cancer medicines.
Veronika Ballová explains how this attractive and interactive book gives a complete overview of what is essential in the rapidly moving field of leukaemia and myeloma. Veronika Ballová is co-editor of the ESMO Leukaemia and Myeloma: Essentials for Clinicians and a member of the ESMO Educational Publications Working Group.
17 Apr 2019
ESMO would like to thank the Hellenic Group of Young Oncologists (HeGYO) for providing translation in Greek on behalf of the Hellenic Society for...
16 Apr 2019
Systemic absorption is of concern because it may result in side effects such as venous thromboembolism, stroke and endometrial cancer
15 Apr 2019
Apply now! Extended application deadline: 19 April 2019.
15 Apr 2019
ESMO would like to thank the Hellenic Group of Young Oncologists (HeGYO) for guide translation into Greek language on behalf of the Hellenic Society...
15 Apr 2019
Approval of FGFR inhibitor is based on data from a cohort of patients enrolled on Study BLC2001
14 Apr 2019
Certificate of attendance is available online
Lugano, Switzerland
26 Apr
- 27 Apr
2019
Berlin, Germany
02 May
- 04 May
2019
Zurich, Switzerland
10 May
- 11 May
2019
Bergamo, Italy
15 May
- 17 May
2019
Valencia, Spain
17 May
- 18 May
2019
Kazan, Russian Federation
10 Jun
- 11 Jun
2019
